Drug diversion bill
Executive Summary
In a Nov. 3 letter to Sen. Matsunaga (D-Hawaii), sponsor of the Senate drug diversion legislation (S 368), Finance Committee Chairman Bensten (D-Texas) indicates that a full committee markup will be scheduled before the end of the year. Rep. Dingell (D-Mich.), the House sponsor, has urged Bentsen to expedite the legislative process ("The Pink Sheet" Oct. 12, T&G-2).